The influence of smoking on uterine bleeding during continuous and interrupted oral hormone therapy
article
OA: closed
CC0
Abstract
OBJECTIVE: To study the influence of smoking on uterine bleeding patterns during continuous and interrupted oral hormone therapy (HT). METHODS: Using a post-hoc strategy, we included five oral HT groups from three studies. The therapies consisted of continuous estrogen (estradiol, estradiol valerate or piperazine estrone sulfate) in combination with continuous progestogen (cyproterone acetate, gestodene or norethisterone acetate) or in combination with interrupted progestogen (norethisterone) given on days 4-6, 10-12, 16-18, 22-24 and 28-30. A total of 145 healthy postmenopausal women (54 smokers and 91 non-smokers), who had been followed for 2 years, were included in the analyses. Uterine bleeding data were collected from bleeding calendars. RESULTS: In general, smoking women experienced significantly less days with uterine bleeding per cycle than non-smoking women during continuous and interrupted HT (0.53 +/- 0.1 vs. 1.6 +/- 0.1; p < 0.001). Smoking women were also more likely than non-smoking women to be amenorrheic during these therapies (48.2% vs. 29.7%; p < 0.05). Finally, more smoking than non-smoking women attained amenorrhea during HT (94.4% vs. 76.9%p < 0.01). CONCLUSIONS: In healthy postmenopausal women, smoking may reduce uterine bleeding during interrupted and continuous HT regimens containing a broad selection of estrogens and progestogens. Further study with appropriate stratification for smoking status is warranted.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (19)
- doi:10.1093/oxfordjournals.humrep.a137791 via openalex
- doi:10.1080/13697130400012171 via openalex
- doi:10.1097/01.gme.0000079740.18541.db via openalex
- doi:10.1210/jcem.85.2.6364 via openalex
- doi:10.1021/tx0200919 via openalex
- doi:10.1080/13697130701258820 via openalex
- W2063579068 via openalex
- doi:10.1111/j.1471-0528.2000.tb13231.x via openalex
- doi:10.1016/s0002-9343(99)00022-4 via openalex
- doi:10.1056/nejm198510173131602 via openalex
- doi:10.1016/s1470-2045(02)00816-1 via openalex
- doi:10.1016/s0029-7844(99)00643-2 via openalex
- doi:10.1056/nejmc051728 via openalex
- doi:10.1007/bf02390832 via openalex
- doi:10.1016/s0002-9343(05)80009-9 via openalex
- doi:10.1111/j.0954-6820.1982.tb03185.x via openalex
- doi:10.1097/01.gme.0000117062.54779.bd via openalex
- doi:10.1111/j.1471-0528.2000.tb13230.x via openalex
- doi:10.1067/mob.2000.106595 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T06:00:05.006021+00:00
License: CC0
· commercial use OK